Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study shows zoonotic potential of bat influenza virus
Experts say the findings are a ‘wake-up call’ for more research.

Virus may be capable of infecting dogs and humans

Bat influenza virus has the potential to infect both dog and human cells, according to new research.


Writing in the journal Proceedings of the National Academy of Science, experts report a breakthrough in isolating bat influenza virus - the first time this has been achieved in a laboratory.


However, the study took an unexpected turn when the team found that bat influenza virus infected not only bat cells but also dog and human cells.


In the study, the team analysed over 30 cells lines from different species for their ability to recognise and internalise bat influenza viruses.

They did this by first using another virus - vesicular stomatitis virus - which can infect many different types of cell. They then proceeded to engineer this virus, so that it could incorporate on its own surface, a bat influenza protein.


Following this, the bat cell line most susceptible to the engineered stomatitis virus was used to reconstruct the original bat influenza virus.

The researchers found that most cells - including human cells and a particular cell line of canine origin - were highly susceptible to infection.
 This suggests that bat influenza has the potential to transmit to dogs and humans, they conclude.  


Speaking to Science Daily, Professor Martin Schwemmle from the University of Freiburg, said that while there is no evidence yet for such transmissions, the new findings are a ‘wake-up call’ for more research.

"It is too early to jump to definite conclusions on the ability of this virus to cross the species barrier and infect humans but our studies make it possible now to conduct further experiments and analyse the risk that these viruses pose for other species," he said.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.